PDCD1 and colorectal cancer: In fact, the iRFA-induced local recruitment of Tregs, monocytes and tumor associated macrophages can inhibit T cell functionality, promote tumor progression, and hinder the efficacy of anti-PD-1 therapy in colorectal cancer liver metastases (8).